Search Results - "Mosley, Scott A."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3

    Determination of Minimum Effective Dose and Optimal Dosing Schedule for Liposomal Curcumin in a Xenograft Human Pancreatic Cancer Model by MACH, Claire M, MATHEW, Lata, MOSLEY, Scott A, KURZROCK, Razelle, SMITH, Judith A

    Published in Anticancer research (01-06-2009)
    “…Background: Curcumin is a food chemical present in tumeric (Curcuma longa) that has pharmacological activity to suppress carcinogenesis and inhibits multiple…”
    Get full text
    Journal Article
  4. 4

    Ligand-specific pharmacogenetic effects of nonsynonymous mutations by Morningstar-Kywi, Noam, Haworth, Ian S., Mosley, Scott A.

    Published in Pharmacogenetics and genomics (01-06-2021)
    “…In pharmacogenomics, variable receptor phenotypes, resulting from genetic polymorphisms, are often described as a change in protein function or regulation…”
    Get full text
    Journal Article
  5. 5

    Changes in anticoagulant and antiplatelet drug supply at US hospitals before and during the COVID-19 pandemic (2018-2021) by Wong, Paul J, Mosley, Scott A, Ng, Tien M H, Shooshtari, Andrew, Alexander, G Caleb, Qato, Dima M

    Published in American journal of health-system pharmacy (24-05-2023)
    “…Abstract Purpose Antithrombotic agents have a role in coronavirus disease 2019 (COVID-19) treatment, but the pandemic disrupted medication supply. This study…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Evaluation of Liposomal Curcumin Cytochrome P450 Metabolism by MACH, Claire M, JING HONG CHEN, MOSLEY, Scott A, KURZROCK, Razelle, SMITH, Judith A

    Published in Anticancer research (01-03-2010)
    “…Curcumin (diferuloylmethane) is a commonly used spice and nutritional supplement that has demonstrated potential anti-tumor and anti-inflammatory activity…”
    Get full text
    Journal Article
  11. 11

    Ligand-specific pharmacogenetic effects of nonsynonymous mutations by Morningstar-Kywi, Noam, Haworth, Ian S., Mosley, Scott A.

    Published in Pharmacogenetics and genomics (30-12-2020)
    “…In pharmacogenomics, variable receptor phenotypes, resulting from genetic polymorphisms, are often described as a change in protein function or regulation…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Guidelines for therapeutic interchange—2022 by Welty, Timothy E., Hilaire, Michelle L., Frantzen, Leah M., Achey, Thomas S., Minze, Molly G., Japs, Kelsey L., Elliott, Amber N., Brasher, Cynthia A., May, Dianne W., Mosley, Scott A., Johnson, Corinne G., Grimm, Derek L., Huffman, Sara

    “…The American College of Clinical Pharmacy (ACCP) Board of Regents charged the 2020 to 2021 Publications Committee to review and revise the 2004 ACCP guideline…”
    Get full text
    Journal Article